The role of F-18-fluoro-2-deoxy-D-glucose positron emission tomography (F-18-FDG-PET) in the diagnosis of recurrence and lymph node metastasis of cervical cancer
N. Umesaki et al., The role of F-18-fluoro-2-deoxy-D-glucose positron emission tomography (F-18-FDG-PET) in the diagnosis of recurrence and lymph node metastasis of cervical cancer, ONCOL REP, 7(6), 2000, pp. 1261-1264
The usefulness of positron emission tomography with 2-[F-18]-fluoro-2-deoxy
-D-glucose (FDG-PET) in diagnosing recurrence and lymph node metastasis of
uterine cervical cancer was evaluated as a preliminary study. The FDG uptak
e of 13 cervical cancer patients, including 4 patients with recurrence, was
evaluated. The FDG uptake of the cervices of 5 patients who underwent PET
studies for non-cervical tumors were used as control. In 2 patients who had
undergone radical hysterectomy, we compared the diagnosis of lymph node me
tastasis based on FDG-PET and magnetic resonance imaging. The FDG uptake in
the 9 primary cervical cancers was greater than that in normal cervices (p
=0.025). Examination of the 4 recurrent tumors revealed a higher FDG uptake
than that in normal cervices (p=0.0022). Metastatic lesions in lymph nodes
showed an accumulation of FDG on the PET scan. In conclusion, FDG-PET may
be an effective diagnostic tool for detecting recurrence and lymph node met
astasis of uterine cervical cancers.